These weight loss medications, administered via injections, work by mimicking a hormone called GLP-1, which helps regulate appetite and blood sugar levels.

The AP-NORC poll results indicate that even as doctors urge the drugs’ use, some Americans continue to have concerns about weight-loss drugs, particularly for people who aren’t struggling with obesity ...

an obesity expert at the University of Washington and one of the 58 authors of the report published in The Lancet Diabetes & Endocrinology journal. The report introduces two new diagnostic ...

A front-of-package food label would be a great educational tool. The Trump administration should keep it.

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

As evidence has mounted that new diabetes and weight loss drugs can provide a variety of health benefits, the FDA has ...

Weight loss jabs, such as Wegovy, have been linked to reduced risk of dementia and seizures – but increased risk of other ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.